NQMC Update Service: October 7, 2013 || Institute for Clinical Systems Improvement

NQMC Update Service: October 7, 2013

NQMC Update Service: October 7, 2013

Agency for Healthcare Research and Quality (AHRQ) sent this bulletin at 10/07/2013 12:36 PM EDT

October 7, 2013

New This Week

Measure Summaries Institute for Clinical Systems Improvement Venous thromboembolism (VTE) diagnosis and treatment: percentage of adult patients with DVT who have been assessed for the need for graduated compression stockings (not T.E.D.sTM). This updates a previously published measure summary. Venous thromboembolism (VTE) diagnosis and treatment: percentage of hospitalized patients with VTE who receive warfarin on day one of heparin therapy. This updates a previously published measure summary. Venous thromboembolism (VTE) diagnosis and treatment: percentage of patients diagnosed with lower extremity VTE who meet the criteria for LMWH and for whom shared decision-making was used prior to implementing therapy. This updates a previously published measure summary. Venous thromboembolism (VTE) diagnosis and treatment: percentage of patients suspected of DVT who have leg duplex ultrasound (DUS) performed, despite a low clinical pretest probability (CPTP) and a negative D-dimer test. This updates a previously published measure summary. Venous thromboembolism (VTE) diagnosis and treatment: percentage of patients with any of these diagnosis – VTE, PE, DVT – indicating a complete list of medications was communicated to the next clinician of service when the patient is referred or transferred to another setting, service, practitioner or level of care within or outside the organization. This updates a previously published measure summary. Venous thromboembolism (VTE) diagnosis and treatment: percentage of patients with suspected VTE who have a clinical pretest probability (CPTP) assessment completed. This updates a previously published measure summary. Venous thromboembolism (VTE) diagnosis and treatment: percentage of patients with VTE treated with LMWH who receive heparin treatment for at least five days after the initiation of warfarin therapy and until INR is greater than or equal to 2.0 for two consecutive days. This updates a previously published measure summary. Venous thromboembolism (VTE) diagnosis and treatment: percentage of patients with VTE treated with UFH who receive heparin treatment for at least five days after the initiation of warfarin therapy and until INR is greater than or equal to 2.0 for two consecutive days. This updates a previously published measure summary. Venous thromboembolism (VTE) diagnosis and treatment: percentage of patients with VTE who are initially prescribed warfarin therapy with documentation in the medical record indicating a baseline INR was obtained. This updates a previously published measure summary. Venous thromboembolism (VTE) diagnosis and treatment: percentage of patients with VTE who are prescribed UFH and LMWH who have appropriate laboratory tests (platelets, PTT for those on UFH) available to monitor and adjust therapy. This updates a previously published measure summary. Venous thromboembolism (VTE) diagnosis and treatment: percentage of patients with VTE who are prescribed UFH and/or LMWH who have baseline laboratory tests documented in their medical record. This updates a previously published measure summary. Venous thromboembolism (VTE) diagnosis and treatment: percentage of patients with VTE who develop PE. This updates a previously published measure summary. Venous thromboembolism (VTE) diagnosis and treatment: percentage of patients with VTE who receive ongoing warfarin therapy with documentation in the medical record indicating a current INR is available and is used to monitor and adjust therapy. This updates a previously published measure summary. Venous thromboembolism (VTE) diagnosis and treatment: percentage of VTE patients who have a high clinical pretest probability (CPTP) (score greater than 6) for PE who received anticoagulation prior to diagnostic evaluation. This updates a previously published measure summary.